Cryptotanshinone significantly reduced blood glucose levels, oxidative stress, inflammation, and NF-κB activation in GDM mice, while increasing insulin levels in the placenta and blood (Wang N. et al., 2020). Here, NFKB1 is linked to gestational diabetes.